CERITD
CERITD (Centre d’Étude et de Recherche sur l’Intensification du Traitement du Diabète) is a French non-profit research-and-care centre focused on clinical research, technology development and delivery of care for people with diabetes. Activities include development and clinical evaluation of closed‑loop insulin delivery systems, multicenter clinical studies, telemedicine services (including remote wound care), patient education and multidisciplinary outpatient/inpatient care. The Fonds Santé Diabète (FSD) is the associated endowment fund that finances research and outreach.
Industries
Products
Artificial pancreas (closed‑loop insulin delivery) — research prototype and clinical system
Development and clinical evaluation of a hybrid closed‑loop insulin delivery system, including algorithm development, patient database curation and multicenter clinical testing leading to regulatory certification in Europe.
Telepied — telemedicine pathway for diabetic foot ulcer management
A telemedicine model combining local caregiver visits and specialist remote support to manage diabetic foot ulcers and reduce rehospitalization.
Descendance cohort — family risk and prospective study
National family‑based cohort and prospective study developed to create a risk equation for future type 2 diabetes in relatives of diabetic patients; cohort recruitment across multiple sites.
Artificial pancreas (closed‑loop insulin delivery) — research prototype and clinical system
Development and clinical evaluation of a hybrid closed‑loop insulin delivery system, including algorithm development, patient database curation and multicenter clinical testing leading to regulatory certification in Europe.
Telepied — telemedicine pathway for diabetic foot ulcer management
A telemedicine model combining local caregiver visits and specialist remote support to manage diabetic foot ulcers and reduce rehospitalization.
Descendance cohort — family risk and prospective study
National family‑based cohort and prospective study developed to create a risk equation for future type 2 diabetes in relatives of diabetic patients; cohort recruitment across multiple sites.
Services
Clinical diabetes care for pump and closed‑loop users
Outpatient and inpatient care, device initiation, follow-up and 24/7 device support for patients using insulin pumps and closed‑loop systems.
Telemedicine programs (telemonitoring and telewound care)
Remote monitoring and teleconsultation services for glycemic control and for management of diabetic foot ulcers (structured telewound pathways).
Clinical research operations and study coordination
Management of clinical study operations including multicenter observational studies, patient recruitment and oversight of investigational sites.
Dietitian and nutritional counseling services
Individual and follow-up consultations for carbohydrate counting, weight management and meal-related insulin adjustments.
Fundraising and donor management via an endowment fund
Collection and administration of donations, issuance of fiscal receipts and financing of research projects through an associated fund.
Clinical diabetes care for pump and closed‑loop users
Outpatient and inpatient care, device initiation, follow-up and 24/7 device support for patients using insulin pumps and closed‑loop systems.
Telemedicine programs (telemonitoring and telewound care)
Remote monitoring and teleconsultation services for glycemic control and for management of diabetic foot ulcers (structured telewound pathways).
Clinical research operations and study coordination
Management of clinical study operations including multicenter observational studies, patient recruitment and oversight of investigational sites.
Dietitian and nutritional counseling services
Individual and follow-up consultations for carbohydrate counting, weight management and meal-related insulin adjustments.
Fundraising and donor management via an endowment fund
Collection and administration of donations, issuance of fiscal receipts and financing of research projects through an associated fund.
Expertise Areas
- Clinical trial management
- Closed‑loop insulin delivery (artificial pancreas) research
- Telemedicine and remote monitoring
- Diabetes nursing and device management
Key Technologies
- Closed‑loop insulin delivery systems (hybrid closed‑loop)
- Continuous glucose monitoring (CGM)
- Insulin pump therapy
- Telemedicine / remote monitoring platforms